D. E. Shaw & Co., Inc.

Position in MGTX — MeiraGTx Holdings plc

CIK 1009207 New York, NY

Position in MGTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,682,933

+$647,918 QoQ

Shares Held

425,281

+11.4% QoQ

Ownership

0.459%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 99.66939505879641.ToString("F0")% Shared 0.ToString("F0")% None 0.3306049412035807.ToString("F0")%

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,382,181,531 across 180 Biotechnology names. MGTX ranks #99 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,682,933	425,281	+11.4%	Shares	Defined	2026-05-15
2025-12-31	$3,035,015	381,763	+120.4%	Shares	Defined	2026-02-17
2025-09-30	$1,425,451	173,202	+286.5%	Shares	Defined	2025-11-14
2025-03-31	$303,818	44,811	-63.8%	Shares	Defined	2025-05-15
2024-12-31	$752,985	123,643	+41.1%	Shares	Defined	2025-02-14
2024-09-30	$365,437	87,635	+26.8%	Shares	Defined	2024-11-14
2024-06-30	$290,944	69,108	+0.5%	Shares	Defined	2024-08-14
2024-03-31	$417,555	68,790	+88.0%	Shares	Defined	2024-05-15
2023-12-31	$256,819	36,584	+250.0%	Shares	Defined	2024-02-14
2020-06-30	$130,884	10,454	0.0%	Shares	Defined	2020-08-14
2020-03-31	$140,501	10,454	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.